These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Experimental study of the pathogenesis of arterial hypertension and ischemic heart disease in monkeys]. Magakian GO Vestn Akad Med Nauk SSSR; 1977; (8):20-5. PubMed ID: 410183 [No Abstract] [Full Text] [Related]
7. Types of working capacity and frequency of development of ischemic heart disease and essential hypertension. Borisova IYu ; Kruchinina NA; Chernigovskaya SV Hum Physiol; 1985; 11(5):322-6. PubMed ID: 3837734 [No Abstract] [Full Text] [Related]
8. [Environmental factors and blood pressure]. Markiewicz A Przegl Lek; 1997; 54(1):31-6. PubMed ID: 9190632 [No Abstract] [Full Text] [Related]
9. Reducing hypertension-associated cardiorenal risk: the role of heart rate, left ventricular hypertrophy regression, and renoprotection. Materson BJ Am J Hypertens; 1999 Jan; 12(1 Pt 2):1S-2S. PubMed ID: 10077412 [No Abstract] [Full Text] [Related]
10. Altered regional blood flow in the fetus: the origins of cardiovascular disease? Barker DJ; Hanson MA Acta Paediatr; 2004 Dec; 93(12):1559-60. PubMed ID: 15841760 [TBL] [Abstract][Full Text] [Related]
11. Coronary risk factors and their modification: lipids, smoking, hypertension, estrogen, and the elderly. Abrams J; Vela BS; Coultas DB; Samaan SA; Malhotra D; Roche RJ Curr Probl Cardiol; 1995 Aug; 20(8):533-610. PubMed ID: 7587343 [No Abstract] [Full Text] [Related]
12. [Isolated systolic hypertension. Need for new assessment]. van der Giet M; Zidek W MMW Fortschr Med; 2003 Feb; 145(7):53-4. PubMed ID: 12652827 [No Abstract] [Full Text] [Related]
20. Doxazosin: A distinctive approach to risk reduction of coronary heart disease in hypertensive patients. Proceedings of a symposium. Hamburg, West Germany, January 30, 1988. Am Heart J; 1988 Dec; 116(6 Pt 2):1707-840. PubMed ID: 2974237 [No Abstract] [Full Text] [Related] [Next] [New Search]